ANUHPHR Q1 FY27 results at a glance
ANUH PHARMA LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹194 cr |
|---|
| Revenue YoY | +3.9% |
|---|
| Operating profit | ₹13.85 cr |
|---|
| Operating margin | 7.1% |
|---|
| Net profit | ₹11.42 cr |
|---|
| Net profit YoY | +37.6% |
|---|
| Net profit QoQ | -2.2% |
|---|
| Net margin | 5.9% |
|---|
| Basic EPS | ₹1.14 |
|---|
| TTM revenue | ₹779 cr |
|---|
| TTM net profit | ₹44.17 cr |
|---|
| TTM net margin | 5.7% |
|---|
ANUHPHR Q1 FY27 results: what the numbers say
ANUH PHARMA LIMITED (ANUHPHR) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹194 cr and a net profit of ₹11.42 cr, translating into earnings per share of ₹1.14.
Compared with the same quarter a year earlier, revenue grew by +3.9% and net profit grew strongly by +37.6%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹13.85 cr, an operating margin of 7.1% versus 4.2% a year ago — a gain of 3.0 percentage points.
ANUHPHR quarter-wise results table
Net profit
₹11.42 cr
+37.6% YoY
Operating profit
₹13.85 cr
+78.2% YoY
ANUH PHARMA LIMITED (ANUHPHR) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹194 cr | ₹13.85 cr | ₹11.42 cr | 7.1% | 5.9% | ₹1.14 | +37.6% | -2.2% |
| Q4 FY262026-03-31 | ₹202 cr | ₹16.88 cr | ₹11.68 cr | 8.4% | 5.8% | ₹1.17 | — | -13.2% |
| Q3 FY262025-12-31 | ₹197 cr | ₹13.8 cr | ₹13.45 cr | 7.0% | 6.8% | ₹1.34 | — | +76.7% |
| Q2 FY262025-09-30 | ₹186 cr | ₹9.02 cr | ₹7.61 cr | 4.9% | 4.1% | ₹0.76 | — | -8.3% |
| Q1 FY262025-06-30 | ₹186 cr | ₹7.78 cr | ₹8.3 cr | 4.2% | 4.5% | ₹1.66 | — | — |
| TTM (last 4 quarters) | ₹779 cr | ₹53.55 cr | ₹44.17 cr | 6.9% | 5.7% | ₹4.41 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
ANUHPHR quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
ANUH PHARMA LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹194 cr | ₹202 cr | ₹197 cr | ₹186 cr | ₹186 cr |
|---|
| Total expenses | ₹180 cr | ₹185 cr | ₹183 cr | ₹177 cr | ₹179 cr |
|---|
| Gross profit | ₹45.5 cr | ₹50.89 cr | ₹45.9 cr | ₹41.35 cr | ₹33.86 cr |
|---|
| Operating profit (EBIT) | ₹13.85 cr | ₹16.88 cr | ₹13.8 cr | ₹9.02 cr | ₹7.78 cr |
|---|
| Operating margin | 7.1% | 8.4% | 7.0% | 4.9% | 4.2% |
|---|
| Interest cost | ₹0 cr | ₹0.11 cr | ₹0.08 cr | ₹0.08 cr | ₹0.21 cr |
|---|
| Profit before tax | ₹16.93 cr | ₹15.52 cr | ₹17.83 cr | ₹9.92 cr | ₹10.95 cr |
|---|
| Tax expense | ₹5.5 cr | ₹3.84 cr | ₹4.38 cr | ₹2.31 cr | ₹2.65 cr |
|---|
| Effective tax rate | 32.5% | 24.7% | 24.6% | 23.3% | 24.2% |
|---|
| Net profit (PAT) | ₹11.42 cr | ₹11.68 cr | ₹13.45 cr | ₹7.61 cr | ₹8.3 cr |
|---|
| Net profit margin | 5.9% | 5.8% | 6.8% | 4.1% | 4.5% |
|---|
| Basic EPS | ₹1.14 | ₹1.17 | ₹1.34 | ₹0.76 | ₹1.66 |
|---|
| Diluted EPS | ₹1.14 | ₹1.17 | ₹1.34 | ₹0.76 | ₹1.66 |
|---|
ANUHPHR results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +3.9% | — | — | — | — |
|---|
| Revenue QoQ | -4.1% | +2.5% | +6.1% | -0.3% | — |
|---|
| Operating profit YoY | +78.2% | — | — | — | — |
|---|
| Operating profit QoQ | -17.9% | +22.3% | +53.0% | +16.0% | — |
|---|
| Net profit YoY | +37.6% | — | — | — | — |
|---|
| Net profit QoQ | -2.2% | -13.2% | +76.7% | -8.3% | — |
|---|
| EPS YoY | -31.3% | — | — | — | — |
|---|
| EPS QoQ | -2.6% | -12.7% | +76.3% | -54.2% | — |
|---|
ANUHPHR annual results history
Full-year performance for ANUH PHARMA LIMITED, useful for reading each quarter in context.
ANUH PHARMA LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹772 cr | ₹662 cr | ₹647 cr | ₹527 cr |
|---|
| Total expenses | ₹715 cr | ₹605 cr | ₹579 cr | ₹483 cr |
|---|
| Gross profit | ₹172 cr | ₹162 cr | ₹160 cr | ₹126 cr |
|---|
| Operating profit (EBIT) | ₹56.94 cr | ₹56.84 cr | ₹67.67 cr | ₹44.45 cr |
|---|
| Operating margin | 7.4% | 8.6% | 10.5% | 8.4% |
|---|
| Interest cost | ₹0.47 cr | ₹0.62 cr | ₹0.35 cr | ₹0.22 cr |
|---|
| Profit before tax | ₹54.22 cr | ₹61.01 cr | ₹78.31 cr | ₹47.47 cr |
|---|
| Tax expense | ₹13.18 cr | ₹13.65 cr | ₹18.25 cr | ₹11.29 cr |
|---|
| Effective tax rate | 24.3% | 22.4% | 23.3% | 23.8% |
|---|
| Net profit (PAT) | ₹41.05 cr | ₹47.35 cr | ₹60.06 cr | ₹36.18 cr |
|---|
| Net profit margin | 5.3% | 7.2% | 9.3% | 6.9% |
|---|
| Basic EPS | ₹4.10 | ₹2.36 | ₹5.99 | ₹3.61 |
|---|
| Diluted EPS | ₹4.10 | ₹2.36 | ₹5.99 | ₹3.61 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹194 cr against ₹186 cr in Q1 FY26, and ₹202 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -4.1%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹180 cr, or 92.9% of revenue, with operating profit grew +78.2% year on year.
Margins, tax and profitability
Net profit of ₹11.42 cr works out to a net margin of 5.9% compared with 4.5% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, ANUH PHARMA LIMITED reported profit before tax of ₹16.93 cr, a tax charge of ₹5.5 cr (effective rate 32.5%), interest cost of ₹0 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹11.68 cr in Q4 FY26 to ₹11.42 cr in Q1 FY27, a change of -2.2%.
Trailing twelve months and annual context
Across the trailing four quarters ANUH PHARMA LIMITED has generated revenue of ₹779 cr and net profit of ₹44.17 cr, a trailing net margin of 5.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹772 cr with net profit of ₹41.05 cr and EPS of ₹4.10, versus the prior year where revenue grew +16.7% and profit declined -13.3%.
What to watch in the next ANUHPHR quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
ANUH PHARMA LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
ANUHPHR results coverage
No results report published for ANUHPHR yet — our desk covers each quarter within minutes of the filing.
ANUHPHR quarterly results FAQs
What were ANUH PHARMA LIMITED (ANUHPHR) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), ANUH PHARMA LIMITED reported revenue of ₹194 cr and net profit of ₹11.42 cr, a change of +37.6% year on year on +3.9% revenue growth. EPS stood at ₹1.14.
What is ANUHPHR profit margin in Q1 FY27?
ANUH PHARMA LIMITED posted a net profit margin of 5.9% and an operating margin of 7.1% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹779 cr and net profit ₹44.17 cr.
Did ANUHPHR results beat the previous quarter?
ANUH PHARMA LIMITED net profit changed -2.2% quarter on quarter, from ₹11.68 cr in Q4 FY26 to ₹11.42 cr in Q1 FY27.
When are ANUH PHARMA LIMITED (ANUHPHR) quarterly results?
ANUH PHARMA LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see ANUHPHR latest quarterly results?
Results coverage for ANUHPHR will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the ANUHPHR stock page.
What is ANUH PHARMA LIMITED annual revenue and profit?
For FY26, ANUH PHARMA LIMITED reported full-year revenue of ₹772 cr and net profit of ₹41.05 cr, with EPS of ₹4.10.
How many quarterly results has ANUHPHR declared recently?
Past results dates for ANUHPHR will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
